[go: up one dir, main page]

SE354061B - - Google Patents

Info

Publication number
SE354061B
SE354061B SE13078/67A SE1307867A SE354061B SE 354061 B SE354061 B SE 354061B SE 13078/67 A SE13078/67 A SE 13078/67A SE 1307867 A SE1307867 A SE 1307867A SE 354061 B SE354061 B SE 354061B
Authority
SE
Sweden
Application number
SE13078/67A
Inventor
L Lunts
P Toon
D Collin
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26253347&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE354061(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of SE354061B publication Critical patent/SE354061B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE13078/67A 1966-09-23 1967-09-22 SE354061B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB18383/67A GB1200886A (en) 1966-09-23 1966-09-23 Phenylaminoethanol derivatives
GB1838367 1967-04-21

Publications (1)

Publication Number Publication Date
SE354061B true SE354061B (de) 1973-02-26

Family

ID=26253347

Family Applications (1)

Application Number Title Priority Date Filing Date
SE13078/67A SE354061B (de) 1966-09-23 1967-09-22

Country Status (15)

Country Link
US (3) US3644353A (de)
AT (1) AT280996B (de)
BE (1) BE704037A (de)
CH (1) CH492676A (de)
CS (1) CS167874B2 (de)
CY (1) CY713A (de)
DE (1) DE1643224C3 (de)
DK (1) DK133618B (de)
FR (2) FR8010M (de)
GB (1) GB1200886A (de)
IL (1) IL28643A (de)
NL (2) NL160805C (de)
NO (1) NO126014B (de)
PL (1) PL70430B1 (de)
SE (1) SE354061B (de)

Families Citing this family (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE368197B (de) * 1968-11-18 1974-06-24 Pfizer
US4101579A (en) * 1969-02-06 1978-07-18 Allen & Hanburys Limited Phenethanolamine ethers
GB1266058A (de) * 1969-07-08 1972-03-08
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
GB1298494A (en) * 1970-06-17 1972-12-06 Allen & Hanburys Ltd Phenylethanolamine derivatives
AT310146B (de) * 1971-04-26 1973-09-25 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen N,N'-Bis-(β-hydroxyaryläthyl)-diaminoalkanen und deren Säureadditionssalzen
BE794414A (fr) * 1972-01-25 1973-07-23 Sandoz Sa Nouveaux amino-alcools, leur preparation et leur application comme medicament
US4018825A (en) * 1972-07-27 1977-04-19 Warner-Lambert Company 5-Hydroxy-α-(substituted aminomethyl)-m-xylene-α,α'-diols
US4024255A (en) * 1973-04-05 1977-05-17 Allen & Hanburys Limited Tetrazole containing naphthyridine-3-carboxamides
US4000192A (en) * 1973-05-07 1976-12-28 Allen & Hanburys Limited Pharmacologically active compounds
GB1468673A (en) * 1973-05-07 1977-03-30 Allen & Hanburys Ltd Substituted benzamides
US3883560A (en) * 1973-07-05 1975-05-13 Colgate Palmolive Co Salicylamidophenethanolamines
US4046913A (en) * 1973-08-18 1977-09-06 Boehringer Ingelheim Gmbh 1-(M-alkanoyloxy-phenyl)-1-hydroxy-2-(N-lower alkyl-amino)-ethanes and salts thereof
US4026897A (en) * 1974-01-31 1977-05-31 Otsuka Pharmaceutical Company 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives
US4093628A (en) * 1974-04-18 1978-06-06 American Home Products Corporation Thiophene ethanolamines
US4012528A (en) * 1974-06-03 1977-03-15 Smithkline Corporation α-AMINOALKYL-3-(1,2-DIHYDROXYETHYL)-4-HYDROXY-BENZYL ALCOHOLS HAVING β-ADRENERGIC STIMULANT ACTIVITY
US4173583A (en) * 1975-04-17 1979-11-06 Schering Corporation Diastereoisomers of 5-(1-hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide
US4160036A (en) * 1975-07-29 1979-07-03 Allen & Hanburys Limited 4-Hydroxy-1,3-benzenedimethanol derivatives
GB1529972A (en) * 1975-07-29 1978-10-25 Allen & Hanburys Ltd Basic alcohols
US4154761A (en) * 1976-02-09 1979-05-15 Allen & Hanburys Limited Pharmacologically active compounds
JPS52113934A (en) * 1976-03-19 1977-09-24 Eisai Co Ltd Phenethylamine derivatives and bronchodilator containing the same
US4055658A (en) * 1976-05-17 1977-10-25 Mead Johnson & Company Cyanomethylphenethanolamines
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
US4163053A (en) * 1977-12-27 1979-07-31 Schering Corporation Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxyalkyl]salicylamides
DK160936C (da) * 1978-07-03 1991-10-21 Lilly Co Eli Analogifremgangsmaade til fremstilling af optisk aktive phenethanolaminer
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
DE2935062A1 (de) * 1978-09-06 1980-03-20 Degussa Substituierte aminoalkylguanidine, deren herstellung und arzneimittel
US4950783A (en) * 1978-09-20 1990-08-21 Schering Corporation Treatment of hypertension
US4275074A (en) * 1979-03-09 1981-06-23 Graham J. Dobbie Catecholamine treatment of ocular hypertension
US4590210A (en) * 1979-03-09 1986-05-20 Langham Maurice E Compositions for treatment of ocular hypertension
IT1148741B (it) * 1980-11-28 1986-12-03 Zambeletti Spa L Procedimento per la preparazione dell'1-(3,5-dimetossi-4-idrossifenil)-2-(n-metilammino)etanolo cloridrato
US4348398A (en) * 1980-12-23 1982-09-07 Merck Sharp & Dohme (I.A.) Corp. Quinolinyl ethanolamines
US4486446A (en) * 1980-12-23 1984-12-04 Merck & Co., Inc. Aralkylaminoethanol heterocyclic compounds
US4358455A (en) * 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
US4379166A (en) * 1981-08-03 1983-04-05 Schering Corporation Arylmethoxy-, arylmethylthio-, heteroarylmethoxy-, and heteroarylmethylthio-alkylaminoalcohols
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
GB2120942B (en) * 1982-05-27 1985-10-30 Glaxo Group Ltd Salbutamol compositions
US4594359B1 (en) * 1982-05-27 1994-07-26 Glaxo Group Ltd Pharmaceutical compositions
CH656308A5 (fr) * 1982-05-27 1986-06-30 Glaxo Group Ltd Compositions pharmaceutiques contenant du salbutamol.
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
US4851229A (en) * 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
US4853381A (en) * 1984-04-17 1989-08-01 Glaxo Group Limited Ethanolamine compounds
IL74940A (en) * 1984-04-17 1988-06-30 Glaxo Group Ltd Phenethanolamine compounds,their preparation and pharmaceutical compositions containing them
JPS6183147A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
US5250546A (en) * 1984-09-28 1993-10-05 Nippon Chemiphar Co., Ltd. Amino-alcohol derivatives and processes for their preparation
EP0259159A3 (de) * 1986-09-05 1989-08-09 Schering Corporation Verfahren zur Herstellung von alpha 1-[[(1,1-Dimethylethyl(amino]methyl]-4-hydroxy-1,3-benzendimethanol und bei ihrer Herstellung verwendete Zwischenprodukte
US4952729A (en) * 1986-09-05 1990-08-28 Schering-Plough Corp. Intermediates in the preparation of alpha1(((1,1-dimethylethyl) amino) methyl)-4-hydroxy-1,3-benzenedimethanol
US5011993A (en) * 1986-09-05 1991-04-30 Schering Corporation Method for the preparation of α1 [[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol
US5453418A (en) * 1988-03-07 1995-09-26 Eli Lilly And Company Ractopamine and growth hormone combinations
US5030640A (en) * 1989-01-05 1991-07-09 Merck & Co., Inc. Novel β-adrenergic agonists and pharmaceutical compositions thereof
US5166437A (en) * 1989-03-03 1992-11-24 Orion-Yhtyma Oy Process for the preparation of fluoxetine
GB8909273D0 (en) * 1989-04-24 1989-06-07 Glaxo Group Ltd Chemical compounds
TW197380B (de) * 1990-03-02 1993-01-01 Glaxo Group Ltd
SK280967B6 (sk) 1990-03-02 2000-10-09 Glaxo Group Limited Inhalačný prístroj
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
US5118683A (en) * 1990-06-13 1992-06-02 Schering Corporation Esters of 4-hydroxy-1,3-benzenedimethanol and compositions and methods employing such compounds
WO1991019693A1 (en) * 1990-06-13 1991-12-26 Schering Corporation Esters and cyclic diesters of 4-hydroxy-1,3-benzenedimethanol and compositions and methods employing such compounds
US5011845A (en) * 1990-06-13 1991-04-30 Schering Corporation Cyclic diesters of 4-hydroxy-1,3-benzenedimethanol and compositions and methods employing such compounds
EP0548224B1 (de) * 1990-09-11 1994-11-23 Schering Corporation Verfahren zur herstellung von albuterol, sowie von arylglyoxal-, acetal-, hemiacetal- und hydrat-zwischenprodukten
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
DE69231991T2 (de) 1991-06-10 2002-04-04 Schering Corp., Kenilworth Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
DE69208660T2 (de) * 1991-06-10 1996-07-11 Schering Corp., Kenilworth, N.J. Fluorchlorkohlenwasserstoffreie aerosolformulierungen
NO179246C (no) * 1991-11-20 1996-09-04 Sankyo Co Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
ATE150296T1 (de) * 1991-12-18 1997-04-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5475138A (en) * 1994-07-07 1995-12-12 Pharm-Eco Laboratories Incorporated Method preparing amino acid-derived diaminopropanols
DK0820322T3 (da) 1995-04-14 2002-10-07 Smithkline Beecham Corp Dosisudmålende inhalator til Fluticason Propionat
SK281746B6 (sk) * 1995-04-14 2001-07-10 Glaxo Wellcome Inc. Merací dávkovací inhalátor, neplnený merací dávkovací inhalátor a merací dávkovací inhalačný systém
DK0820323T3 (da) 1995-04-14 2003-11-24 Smithkline Beecham Corp Inhalator til afmålte doser af salmeterol
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
EP0801060A1 (de) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclische Beta-3 adrenergische Angonisten
US20030103906A1 (en) * 1997-10-14 2003-06-05 Smithkline Beecham Corporation Metered dose inhaler having internal surfaces coated with fluorocarbon polymer
ZA994264B (en) * 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) * 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
GB0030171D0 (en) 2000-12-11 2001-01-24 Cipla Ltd Process for preparing isomers of salbutamol
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
KR20050010512A (ko) * 2002-06-12 2005-01-27 스미또모 세이야꾸 가부시키가이샤 인돌, 인다졸 및 벤즈아졸류
DE10249576B3 (de) * 2002-10-24 2004-04-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von (R)-Salbutamol
US20040127733A1 (en) 2002-10-31 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, processes for preparing them and their use as pharmaceutical compositions
DE10251170A1 (de) * 2002-10-31 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
KR20100080865A (ko) * 2002-12-10 2010-07-12 세프라코 아이엔시. 레발부테롤 염
TW200418825A (en) * 2002-12-16 2004-10-01 Hoffmann La Roche Novel (R)-and (S) enantiomers of thiophene hydroxamic acid derivatives
EA009646B1 (ru) * 2003-05-30 2008-02-28 Рэнбакси Лабораториз Лтд. Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa
AR045536A1 (es) * 2003-08-29 2005-11-02 Ranbaxy Lab Ltd Inhibidores de la fosfodiesterasa tipo -iv
WO2005025506A2 (en) * 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
WO2005041931A2 (en) * 2003-10-20 2005-05-12 Schering Corporation Pharmaceutical aerosol compositions
WO2005051931A2 (en) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1577292A1 (de) * 2004-03-17 2005-09-21 Pfizer Limited Phenylaminoethanolderivate als Agonisten von beta2 Rezeptoren
DE102004021779A1 (de) 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
ES2265276B1 (es) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
WO2007008427A2 (en) * 2005-07-08 2007-01-18 Xemplar Pharmaceuticals, Llc Aerosol compositions and methods
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
BRPI0617674A2 (pt) 2005-10-19 2011-08-02 Ranbaxy Lab Ltd composições farmacêuticas e seus usos
DE102005052127A1 (de) 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1948599A1 (de) * 2005-11-08 2008-07-30 Ranbaxy Laboratories Limited Verfahren zur herstellung von (3r,5r)-7-[2-(4-fluorphenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino)carbonyl]pyrrol-1-yl]-3,5-dihydroxyheptansäure-hemicalciumsalz
TW200744583A (en) * 2006-03-14 2007-12-16 Ranbaxy Lab Ltd Statin stabilizing dosage formulations
CN100398512C (zh) * 2006-04-21 2008-07-02 华南农业大学 （±）α-[（取代胺基）甲基]-苯环取代基-苯甲醇类化合物的制备方法
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
CN101494980A (zh) * 2006-07-14 2009-07-29 兰贝克赛实验室有限公司 HMG-CoA还原酶抑制剂的多晶型形式及其应用
CA2661299A1 (en) 2006-08-22 2008-02-28 Ranbaxy Laboratories Limited Beta -hydroxy-and amino-substituted carboxylic acids as matrix metalloproteinase inhibitors
EP2066661A2 (de) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesteraseinhibitoren
JP2010504323A (ja) * 2006-09-22 2010-02-12 ランバクシー ラボラトリーズ リミテッド Ｉｖ型ホスホジエステラーゼの阻害物質
ES2306595B1 (es) 2007-02-09 2009-09-11 Laboratorios Almirall S.A. Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
DK2120875T3 (en) * 2007-02-11 2018-10-22 Map Pharmaceuticals Inc METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO POSSIBLE QUICK PREVENTION OF MIGRANE AT THE MINIMUM OF THE SIDE EFFECT PROFILE
EP1958947A1 (de) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitoren für Phosphodiesterase Typ 4
MX2009009793A (es) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
EP2124943A1 (de) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridinderivate als phosphodiesterasehemmer
ES2615389T3 (es) 2007-10-05 2017-06-06 Acucela, Inc. Alcoxifenilpropilaminas para el tratamiento de la degeneración macular relacionada con la edad
ES2320961B1 (es) 2007-11-28 2010-03-17 Laboratorios Almirall, S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
EP2111861A1 (de) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Zusammensetzungen von Phosphodiesterase-IV-Hemmern
UY32297A (es) 2008-12-22 2010-05-31 Almirall Sa Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
CN101575298B (zh) * 2008-12-31 2013-03-06 上海予利化学科技有限公司 一种制备手性医药中间体2-氨基-1-苯乙醇的方法
EP2228368A1 (de) 2009-03-12 2010-09-15 Almirall, S.A. Verfahren zur Herstellung von 5-(2-{[6-(2,2-Difluor-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on
WO2010151804A1 (en) * 2009-06-26 2010-12-29 Map Pharmaceuticals, Inc. Administration of dihydroergotamine mesylate particles using a metered dose inhaler
WO2011003103A2 (en) * 2009-07-02 2011-01-06 Acucela, Inc. Pharmacology of visual cycle modulators
WO2012014114A1 (en) 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Matrix metalloproteinase inhibitors
EA201390404A1 (ru) 2010-09-24 2013-09-30 Ранбакси Лабораториз Лимитед Ингибиторы матричной металлопротеиназы
CN102584609B (zh) * 2011-01-06 2015-05-27 上海医药工业研究院 一种沙美特罗的制备方法
EP2578570A1 (de) 2011-10-07 2013-04-10 Almirall, S.A. Neues Verfahren zur Herstellung von 5-(2-{[6-(2,2-Difluor-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxychinolin-2(1H)-on mittels neuen Synthesezwischenstoffen
WO2013109991A1 (en) 2012-01-20 2013-07-25 Acucela Inc. Substituted heterocyclic compounds for disease treatment
EP2641900A1 (de) 2012-03-20 2013-09-25 Almirall, S.A. Neuartige polymorphe Kristallformen von 5-(2-{[6-(2,2-difluor-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on, Heminapadisylat als Agonist des beta2-adrenergen Rezeptors
CN102924382B (zh) * 2012-10-10 2014-11-19 淮海工学院 双水杨醛功能化的咪唑型双子离子液体及其制备方法
CN103086916B (zh) * 2012-10-10 2015-06-24 淮海工学院 席夫碱功能化的双子离子液体
JP6039100B2 (ja) 2012-12-03 2016-12-07 ファイザー・インク 新規選択的アンドロゲン受容体モジュレーター
EP3042892A1 (de) 2015-01-09 2016-07-13 Deva Holding Anonim Sirketi Amorphisierung von Levosalbutamoltartrat
CN108947831A (zh) * 2018-07-13 2018-12-07 重庆康刻尔制药有限公司 一种沙丁胺醇中间体ⅲ的纯化方法
CN108623486A (zh) * 2018-07-13 2018-10-09 重庆康刻尔制药有限公司 一种沙丁胺醇中间体ⅴ盐酸盐的制备方法
CN112920064A (zh) * 2021-05-11 2021-06-08 仁合诚益医药技术(天津)有限公司 一种沙丁胺醇杂质化合物及其制备方法、检测方法和用途
SMT202400370T1 (it) 2021-07-09 2024-11-15 Astrazeneca Pharmaceuticals Lp Composizioni, metodi e sistemi per la somministrazione di un farmaco tramite aerosol
CN114159385A (zh) * 2021-09-27 2022-03-11 北京四环科宝制药股份有限公司 含有硫酸沙丁胺醇的药物组合物及其制备方法
EP4452230A1 (de) 2021-12-20 2024-10-30 Astrazeneca AB Zusammensetzungen, verfahren und systeme zur aerosolwirkstofffreisetzung
GB202304652D0 (en) * 2023-03-29 2023-05-10 Atrogi Ab New compounds and medical uses thereof
CN116283619A (zh) * 2023-03-30 2023-06-23 河北广祥制药有限公司 一种硫酸沙丁胺醇杂质及其制备方法

Also Published As

Publication number Publication date
US3642896A (en) 1972-02-15
NL160805C (nl) 1979-12-17
AT280996B (de) 1970-05-11
FR1557677A (de) 1969-02-21
US3705233A (en) 1972-12-05
DK133618B (da) 1976-06-21
DE1643224C3 (de) 1979-08-09
GB1200886A (en) 1970-08-05
PL70430B1 (en) 1974-02-28
DE1643224A1 (de) 1972-03-02
NL7809942A (nl) 1979-01-31
IL28643A (en) 1971-12-29
CY713A (en) 1973-11-26
NO126014B (de) 1972-12-11
NL160805B (nl) 1979-07-16
CS167874B2 (de) 1976-05-28
BE704037A (de) 1968-02-01
DE1643224B2 (de) 1978-11-23
US3644353A (en) 1972-02-22
CH492676A (de) 1970-06-30
NL6713016A (de) 1968-03-25
DK133618C (de) 1976-11-08
FR8010M (de) 1970-07-27

Similar Documents

Publication Publication Date Title
AU5917865A (de)
AU428063B2 (de)
AU424443B2 (de)
AU414526B2 (de)
AU433222B2 (de)
AU421822B2 (de)
AU417216B2 (de)
AU415165B1 (de)
AU1144366A (de)
AU612166A (de)
AU6703465A (de)
AU5895065A (de)
AU1111066A (de)
AU218666A (de)
BE284991A (de)
BE597652A (de)
AU433620A (de)
AU415780B2 (de)
AU407778B2 (de)
AU411645B2 (de)
BE693951A (de)
BE692663A (de)
AU6852465A (de)
AU855865A (de)
AU92366A (de)